Theravance Biopharma (TBPH) Earnings Date & Reports

Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

TBPH is expected to report earnings to fall 353.27% to 27 cents per share on November 10

Theravance Biopharma TBPH Stock Earnings Reports

Q3'26

Est.

$0.28

Q2'26

Missed

by $0.17

Q1'26

Missed

by $0.07

Q4'25

Beat

by $0.15

Q3'25

Beat

by $0.20

The last earnings report on August 10 showed earnings per share of -10 cents, missing the estimate of 5 cents. With 6.53M shares outstanding, the current market capitalization sits at 884.18M.

View a ticker or compare two or three

TBPH

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for TBPH